Literature DB >> 12673185

Pharmacologic stress testing: new methods and new agents.

Robert C Hendel1, Tariq Jamil, David K Glover.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12673185     DOI： 10.1067/mnc.2003.5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  51 in total

1.  Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease.

Authors:  M L Ladenheim; B H Pollock; A Rozanski; D S Berman; H M Staniloff; J S Forrester; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1986-03       Impact factor: 24.094

2.  Tolerance and diagnostic accuracy of an abbreviated adenosine infusion for myocardial scintigraphy: a randomized, prospective study.

Authors:  M G Treuth; G A Reyes; Z X He; E Cwajg; J J Mahmarian; M S Verani
Journal:  J Nucl Cardiol       Date:  2001 Sep-Oct       Impact factor: 5.952

3.  Comparison of 3- versus 6-minute infusions of adenosine in thallium-201 myocardial perfusion imaging.

Authors:  B J Villegas; R C Hendel; S T Dahlberg; B A McSherry; J A Leppo
Journal:  Am Heart J       Date:  1993-07       Impact factor: 4.749

4.  Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial.

Authors:  P C Albro; K L Gould; R J Westcott; G W Hamilton; J L Ritchie; D L Williams
Journal:  Am J Cardiol       Date:  1978-11       Impact factor: 2.778

5.  Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population.

Authors:  D A Calnon; P D McGrath; A L Doss; F E Harrell; D D Watson; G A Beller
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

6.  Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging.

Authors:  M D Elliott; T A Holly; S M Leonard; R C Hendel
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

7.  Pathophysiological basis for noninvasive functional evaluation of coronary stenosis.

Authors:  A L'Abbate
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

8.  Effects of dobutamine stress on myocardial blood flow, 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses: implications for dobutamine stress testing.

Authors:  D A Calnon; D K Glover; G A Beller; G Vanzetto; W H Smith; D D Watson; M Ruiz
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

9.  Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium-99m-sestamibi imaging.

Authors:  J C Wu; J J Yun; E N Heller; D P Dione; P DeMan; Y H Liu; B L Zaret; F J Wackers; A J Sinusas
Journal:  J Nucl Med       Date:  1998-03       Impact factor: 10.057

10.  Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease.

Authors:  S Borges-Neto; J J Mahmarian; A Jain; R Roberts; M S Verani
Journal:  J Am Coll Cardiol       Date:  1988-05       Impact factor: 24.094
View more
  6 in total

Review 1.  Selective adenosine agonists and myocardial perfusion imaging.

Authors:  Gilbert J Zoghbi; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

2.  Best patient preparation before and during radionuclide myocardial perfusion imaging studies.

Authors:  Lisa A Boger; Lyndy L Volker; Ginger K Hertenstein; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

Review 3.  Advances in pharmacologic agents in imaging: new A2A receptor agonists.

Authors:  Manuel D Cerqueira
Journal:  Curr Cardiol Rep       Date:  2006-03       Impact factor: 2.931

4.  Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease.

Authors:  Punitha Arasaratnam; Masoud Sadreddini; Yeung Yam; Vinay Kansal; Sharmila Dorbala; Marcelo F Di Carli; Rob S Beanlands; Michael E Merhige; Brent A Williams; Emir Veledar; James K Min; Li Chen; Terrence D Ruddy; Guido Germano; Daniel S Berman; Leslee J Shaw; Benjamin J W Chow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-27       Impact factor: 9.236

Review 5.  Adenosine and Its Receptors: An Expected Tool for the Diagnosis and Treatment of Coronary Artery and Ischemic Heart Diseases.

Authors:  Marine Gaudry; Donato Vairo; Marion Marlinge; Melanie Gaubert; Claire Guiol; Giovanna Mottola; Vlad Gariboldi; Pierre Deharo; Stéphane Sadrin; Jean Michel Maixent; Emmanuel Fenouillet; Jean Ruf; Regis Guieu; Franck Paganelli
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

6.  Does dipyridamole-induced ischaemia affect NT-proBNP secretion?

Authors:  Jacques De Greef; Radha Govender; William Vermaak; Nalini Perumal; Elena Libhaber; Mboyo-Di-Tamba Vangu
Journal:  Cardiovasc J Afr       Date:  2007 Nov-Dec       Impact factor: 1.167
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.